Reversal of myelofibrosis in Hodgkin disease.
D000328:Adult; D000741:Anemia, Aplastic / Q000175:diagnosis; D001707:Biopsy, Needle; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D055728:Primary Myelofibrosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013431:Sulfates / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D013431:Sulfates; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone